| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Over the last 12 months, insiders at Vyome Holdings, Inc. have bought $0 and sold $0 worth of Vyome Holdings, Inc. stock.
On average, over the past 5 years, insiders at Vyome Holdings, Inc. have bought $42,865 and sold $68,239 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,702 shares for transaction amount of $26,907 was made by STANKOVICH THOMAS (Chief Financial Officer) on 2023‑06‑30.
| 2024-05-31 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 48 <0.0001% | $0.25 | $12 | -65.83% | |
| 2024-02-29 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 43 <0.0001% | $0.17 | $7 | -3.57% | |
| 2023-12-31 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 42 <0.0001% | $0.25 | $11 | -36.91% | |
| 2023-11-30 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 39 <0.0001% | $0.23 | $9 | -23.68% | |
| 2023-10-25 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 131 0.0002% | $0.27 | $35 | -26.40% | |
| 2023-10-11 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 39 0.0002% | $0.93 | $36 | -28.70% | |
| 2023-09-01 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 118 0.0006% | $0.89 | $105 | -77.61% | |
| 2023-08-24 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 39 0.0003% | $1.42 | $55 | -82.07% | |
| 2023-08-04 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 108 0.0009% | $1.43 | $154 | -84.79% | |
| 2023-07-06 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 106 0.0009% | $1.47 | $156 | -83.66% | |
| 2023-06-30 | STANKOVICH THOMAS | Chief Financial Officer | 17,702 0.1499% | $1.52 | $26,907 | -84.12% | ||
| 2023-05-31 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 98 0.0013% | $2.41 | $236 | -89.67% | |
| 2023-04-30 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 96 0.0013% | $2.36 | $227 | -89.94% | |
| 2023-03-31 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 109 0.0016% | $2.60 | $283 | -85.06% | |
| 2023-02-28 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 103 0.0024% | $4.25 | $438 | -76.97% | |
| 2023-02-02 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 157 0.0116% | $13.29 | $2,087 | -78.25% | |
| 2023-01-24 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 158 0.0066% | $7.49 | $1,183 | -81.24% | |
| 2022-12-01 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 7,357 0.0062% | $0.15 | $1,112 | -70.06% | |
| 2022-11-28 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 364,756 0.3444% | $0.17 | $61,826 | -68.05% | |
| 2022-11-04 | Sale | STANKOVICH THOMAS | Chief Financial Officer | 8,393 0.0127% | $0.27 | $2,287 | -82.32% |
| Increased Positions | 7 | +100% | 87,564 | +225.03% |
| Decreased Positions | 3 | -42.86% | 32,731 | -84.12% |
| New Positions | 5 | New | 83,914 | New |
| Sold Out Positions | 3 | Sold Out | 32,731 | Sold Out |
| Total Postitions | 11 | +57.14% | 93,745 | +140.92% |